Researchers' deepening understanding of how tumors develop could one day provide the basis for preventing various cancers, says an expert.
Phase 3 Data for Bimekizumab Shows Well Maintained Response
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
FDA Approves Adalimumab-Adaz High-Concentration Formulation
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Skin Barrier 101: Keep Up with What Your Patients Are Reading
Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement
2 Clarke Drive Cranbury, NJ 08512